NAYA Biosciences Operating Margin 2010-2024 | IVF

Current and historical operating margin for NAYA Biosciences (IVF) over the last 10 years. The current operating profit margin for NAYA Biosciences as of September 30, 2024 is -119.91%.
NAYA Biosciences Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-09-30 $0.01B $-0.01B -100.00%
2024-06-30 $0.01B $-0.01B -100.00%
2024-03-31 $0.00B $-0.01B -150.00%
2023-12-31 $0.00B $-0.01B -350.00%
2023-09-30 $0.00B $-0.01B -800.00%
2023-06-30 $0.00B $-0.01B 0.00%
2023-03-31 $0.00B $-0.01B 0.00%
2022-12-31 $0.00B $-0.01B 0.00%
2022-09-30 $0.00B $-0.01B -266.67%
2022-06-30 $0.00B $-0.01B -233.33%
2022-03-31 $0.00B $-0.01B -200.00%
2021-12-31 $0.00B $-0.01B -125.00%
2021-09-30 $0.00B $-0.01B -800.00%
2021-06-30 $0.00B $-0.01B -700.00%
2021-03-31 $0.00B $-0.01B -600.00%
2020-12-31 $0.00B $-0.01B 0.00%
2020-09-30 $0.00B $0.00B 0.00%
2020-06-30 $0.00B $0.00B 0.00%
2020-03-31 $0.00B $0.00B -300.00%
2019-12-31 $0.00B $0.00B -200.00%
2019-09-30 $0.00B $0.00B -200.00%
2019-06-30 $0.00B $0.00B -100.00%
2019-03-31 $0.00B $0.00B 0.00%
2018-12-31 $0.00B $0.00B 0.00%
2018-09-30 $0.00B $0.00B 0.00%
2018-06-30 $0.00B $0.00B 0.00%
2018-03-31 $0.00B 0 0.00%
2017-12-31 $0.00B 0 0.00%
2017-09-30 $0.00B 0 0.00%
2017-06-30 $0.00B 0 0.00%
2017-03-31 $0.00B $0.00B 0.00%
2016-12-31 $0.00B $0.00B 0.00%
2016-06-30 $0.00B $0.00B 0.00%
2016-03-31 $0.00B 0 0.00%
2015-09-30 $0.00B 0 0.00%
2015-06-30 $0.00B 0 0.00%
2015-03-31 $0.00B 0 0.00%
2011-12-31 $0.00B 0 0.00%
2011-09-30 $0.00B 0 0.00%
2011-03-31 $0.00B 0 0.00%
2010-12-31 $0.00B 0 0.00%
2010-06-30 $0.00B 0 0.00%
2010-03-31 $0.00B 0 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.002B $0.007B
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
Stock Name Country Market Cap PE Ratio
SAG Holdings (INEO) Singapore $0.014B 0.00
Aerovate Therapeutics (JBIO) United States $0.008B 0.00